Journal
/
Bioingeniería
/
Rapid Isolation of Viable Circulating Tumor Cells from Patient Blood Samples
JoVE Revista
Bioingeniería
This content is Free Access.
JoVE Revista Bioingeniería
Rapid Isolation of Viable Circulating Tumor Cells from Patient Blood Samples

Rapid Isolation of Viable Circulating Tumor Cells from Patient Blood Samples

26,362 Views

•

07:32 min

•

June 15, 2012

DOI:

10.3791/4248-v

DOI:
10.3791/4248-v

•

07:32 min
June 15, 2012

•

3 Views
, , , ,
1Department of Biomedical Engineering,Cornell University, 2BioCytics, Inc., 3Carolina BioOncology Institute, PLLC

Summary

Automatically generated

Circulating tumor cells are isolated from the blood of cancer patients without inflicting cellular damage. Isolation of tumor cells is accomplished using a bimolecular surface of E-selectin in addition to antibodies against epithelial markers. A nanotube coating specifically promotes cancer cell adhesion resulting in high capture purities.

Explore More Videos

CTC IsolationCirculating Tumor CellsViable CTCPatient Blood SamplesDisease ProgressionCTC ConcentrationPersonalized TherapiesCellular DamageLeukocytes ContaminationCTC EnumerationMicrofluidic DeviceE-selectin GlycoproteinEpithelial MarkersNanoparticle CoatingHalloysite Nanotubes

Read Article

Cite this Article

Hughes, A. D., Mattison, J., Powderly, J. D., Greene, B. T., King, M. R. Rapid Isolation of Viable Circulating Tumor Cells from Patient Blood Samples. J. Vis. Exp. (64), e4248, doi:10.3791/4248 (2012).

Download .ris file

Copy

Share Video

.

Copy